nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—SLCO1A2—Chlorambucil—testicular cancer	0.809	0.848	CbGbCtD
Rocuronium—SLCO1A2—Methotrexate—testicular cancer	0.145	0.152	CbGbCtD
Rocuronium—Wheezing—Bleomycin—testicular cancer	0.00156	0.0336	CcSEcCtD
Rocuronium—Respiratory failure—Ifosfamide—testicular cancer	0.0014	0.0301	CcSEcCtD
Rocuronium—Apnoea—Etoposide—testicular cancer	0.00128	0.0276	CcSEcCtD
Rocuronium—Cardiovascular disorder—Etoposide—testicular cancer	0.00124	0.0266	CcSEcCtD
Rocuronium—Hiccups—Cisplatin—testicular cancer	0.00118	0.0255	CcSEcCtD
Rocuronium—Wheezing—Cisplatin—testicular cancer	0.00115	0.0248	CcSEcCtD
Rocuronium—Bronchospasm—Bleomycin—testicular cancer	0.000992	0.0214	CcSEcCtD
Rocuronium—Paralysis—Methotrexate—testicular cancer	0.000936	0.0202	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Cisplatin—testicular cancer	0.000888	0.0191	CcSEcCtD
Rocuronium—Paralysis—Epirubicin—testicular cancer	0.000876	0.0189	CcSEcCtD
Rocuronium—Bronchospasm—Ifosfamide—testicular cancer	0.000848	0.0183	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Etoposide—testicular cancer	0.000814	0.0175	CcSEcCtD
Rocuronium—Paralysis—Doxorubicin—testicular cancer	0.00081	0.0174	CcSEcCtD
Rocuronium—Apnoea—Methotrexate—testicular cancer	0.000767	0.0165	CcSEcCtD
Rocuronium—Hypertension—Vinblastine—testicular cancer	0.000718	0.0155	CcSEcCtD
Rocuronium—Cardiovascular disorder—Epirubicin—testicular cancer	0.000692	0.0149	CcSEcCtD
Rocuronium—Bronchospasm—Etoposide—testicular cancer	0.00067	0.0144	CcSEcCtD
Rocuronium—Respiratory failure—Methotrexate—testicular cancer	0.000662	0.0143	CcSEcCtD
Rocuronium—Cardiovascular disorder—Doxorubicin—testicular cancer	0.000641	0.0138	CcSEcCtD
Rocuronium—Arrhythmia—Ifosfamide—testicular cancer	0.000616	0.0133	CcSEcCtD
Rocuronium—Hiccups—Epirubicin—testicular cancer	0.000608	0.0131	CcSEcCtD
Rocuronium—Anaphylactic shock—Bleomycin—testicular cancer	0.000574	0.0124	CcSEcCtD
Rocuronium—Hiccups—Doxorubicin—testicular cancer	0.000563	0.0121	CcSEcCtD
Rocuronium—Hypersensitivity—Chlorambucil—testicular cancer	0.000546	0.0118	CcSEcCtD
Rocuronium—Hypotension—Bleomycin—testicular cancer	0.000536	0.0115	CcSEcCtD
Rocuronium—Arrhythmia—Cisplatin—testicular cancer	0.000531	0.0114	CcSEcCtD
Rocuronium—Pruritus—Chlorambucil—testicular cancer	0.000524	0.0113	CcSEcCtD
Rocuronium—Hypertension—Ifosfamide—testicular cancer	0.000519	0.0112	CcSEcCtD
Rocuronium—Hypersensitivity—Vinblastine—testicular cancer	0.0005	0.0108	CcSEcCtD
Rocuronium—Anaphylactic shock—Ifosfamide—testicular cancer	0.00049	0.0106	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Methotrexate—testicular cancer	0.000488	0.0105	CcSEcCtD
Rocuronium—Vomiting—Chlorambucil—testicular cancer	0.000471	0.0101	CcSEcCtD
Rocuronium—Hypotension—Ifosfamide—testicular cancer	0.000458	0.00987	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000456	0.00983	CcSEcCtD
Rocuronium—Nausea—Chlorambucil—testicular cancer	0.00044	0.00948	CcSEcCtD
Rocuronium—Vomiting—Vinblastine—testicular cancer	0.000432	0.0093	CcSEcCtD
Rocuronium—Anaphylactic shock—Cisplatin—testicular cancer	0.000423	0.0091	CcSEcCtD
Rocuronium—Hypersensitivity—Bleomycin—testicular cancer	0.000423	0.0091	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000422	0.00909	CcSEcCtD
Rocuronium—Tachycardia—Cisplatin—testicular cancer	0.000412	0.00888	CcSEcCtD
Rocuronium—Hypertension—Etoposide—testicular cancer	0.00041	0.00882	CcSEcCtD
Rocuronium—Asthma—Methotrexate—testicular cancer	0.000408	0.00878	CcSEcCtD
Rocuronium—Pruritus—Bleomycin—testicular cancer	0.000406	0.00874	CcSEcCtD
Rocuronium—Nausea—Vinblastine—testicular cancer	0.000403	0.00869	CcSEcCtD
Rocuronium—Hypotension—Cisplatin—testicular cancer	0.000395	0.00851	CcSEcCtD
Rocuronium—Hypersensitivity—Dactinomycin—testicular cancer	0.000394	0.00849	CcSEcCtD
Rocuronium—Muscular weakness—Epirubicin—testicular cancer	0.000389	0.00839	CcSEcCtD
Rocuronium—Anaphylactic shock—Etoposide—testicular cancer	0.000387	0.00834	CcSEcCtD
Rocuronium—Asthma—Epirubicin—testicular cancer	0.000382	0.00822	CcSEcCtD
Rocuronium—Tachycardia—Etoposide—testicular cancer	0.000378	0.00814	CcSEcCtD
Rocuronium—Vomiting—Bleomycin—testicular cancer	0.000365	0.00786	CcSEcCtD
Rocuronium—Hypotension—Etoposide—testicular cancer	0.000362	0.00779	CcSEcCtD
Rocuronium—Rash—Bleomycin—testicular cancer	0.000362	0.00779	CcSEcCtD
Rocuronium—Dermatitis—Bleomycin—testicular cancer	0.000361	0.00778	CcSEcCtD
Rocuronium—Hypersensitivity—Ifosfamide—testicular cancer	0.000361	0.00778	CcSEcCtD
Rocuronium—Muscular weakness—Doxorubicin—testicular cancer	0.00036	0.00776	CcSEcCtD
Rocuronium—Asthma—Doxorubicin—testicular cancer	0.000353	0.00761	CcSEcCtD
Rocuronium—Pruritus—Ifosfamide—testicular cancer	0.000347	0.00747	CcSEcCtD
Rocuronium—Nausea—Bleomycin—testicular cancer	0.000341	0.00734	CcSEcCtD
Rocuronium—Vomiting—Dactinomycin—testicular cancer	0.00034	0.00733	CcSEcCtD
Rocuronium—Rash—Dactinomycin—testicular cancer	0.000337	0.00726	CcSEcCtD
Rocuronium—Nausea—Dactinomycin—testicular cancer	0.000318	0.00684	CcSEcCtD
Rocuronium—Vomiting—Ifosfamide—testicular cancer	0.000312	0.00671	CcSEcCtD
Rocuronium—Hypersensitivity—Cisplatin—testicular cancer	0.000311	0.00671	CcSEcCtD
Rocuronium—Rash—Ifosfamide—testicular cancer	0.000309	0.00666	CcSEcCtD
Rocuronium—Dermatitis—Ifosfamide—testicular cancer	0.000309	0.00665	CcSEcCtD
Rocuronium—Nausea—Ifosfamide—testicular cancer	0.000291	0.00627	CcSEcCtD
Rocuronium—Hypersensitivity—Etoposide—testicular cancer	0.000285	0.00614	CcSEcCtD
Rocuronium—Pruritus—Etoposide—testicular cancer	0.000274	0.0059	CcSEcCtD
Rocuronium—Arrhythmia—Epirubicin—testicular cancer	0.000273	0.00588	CcSEcCtD
Rocuronium—Vomiting—Cisplatin—testicular cancer	0.000269	0.00579	CcSEcCtD
Rocuronium—Rash—Cisplatin—testicular cancer	0.000266	0.00574	CcSEcCtD
Rocuronium—Dermatitis—Cisplatin—testicular cancer	0.000266	0.00573	CcSEcCtD
Rocuronium—Arrhythmia—Doxorubicin—testicular cancer	0.000253	0.00544	CcSEcCtD
Rocuronium—Nausea—Cisplatin—testicular cancer	0.000251	0.00541	CcSEcCtD
Rocuronium—Vomiting—Etoposide—testicular cancer	0.000246	0.0053	CcSEcCtD
Rocuronium—Rash—Etoposide—testicular cancer	0.000244	0.00526	CcSEcCtD
Rocuronium—Dermatitis—Etoposide—testicular cancer	0.000244	0.00525	CcSEcCtD
Rocuronium—Anaphylactic shock—Methotrexate—testicular cancer	0.000232	0.005	CcSEcCtD
Rocuronium—Nausea—Etoposide—testicular cancer	0.00023	0.00495	CcSEcCtD
Rocuronium—Hypertension—Epirubicin—testicular cancer	0.00023	0.00495	CcSEcCtD
Rocuronium—Anaphylactic shock—Epirubicin—testicular cancer	0.000217	0.00467	CcSEcCtD
Rocuronium—Hypotension—Methotrexate—testicular cancer	0.000217	0.00467	CcSEcCtD
Rocuronium—Shock—Epirubicin—testicular cancer	0.000214	0.0046	CcSEcCtD
Rocuronium—Hypertension—Doxorubicin—testicular cancer	0.000212	0.00458	CcSEcCtD
Rocuronium—Tachycardia—Epirubicin—testicular cancer	0.000212	0.00456	CcSEcCtD
Rocuronium—Hypotension—Epirubicin—testicular cancer	0.000203	0.00437	CcSEcCtD
Rocuronium—Anaphylactic shock—Doxorubicin—testicular cancer	0.000201	0.00433	CcSEcCtD
Rocuronium—Shock—Doxorubicin—testicular cancer	0.000198	0.00426	CcSEcCtD
Rocuronium—Tachycardia—Doxorubicin—testicular cancer	0.000196	0.00422	CcSEcCtD
Rocuronium—Hypotension—Doxorubicin—testicular cancer	0.000188	0.00404	CcSEcCtD
Rocuronium—Hypersensitivity—Methotrexate—testicular cancer	0.000171	0.00368	CcSEcCtD
Rocuronium—Pruritus—Methotrexate—testicular cancer	0.000164	0.00353	CcSEcCtD
Rocuronium—Hypersensitivity—Epirubicin—testicular cancer	0.00016	0.00344	CcSEcCtD
Rocuronium—Pruritus—Epirubicin—testicular cancer	0.000154	0.00331	CcSEcCtD
Rocuronium—Hypersensitivity—Doxorubicin—testicular cancer	0.000148	0.00319	CcSEcCtD
Rocuronium—Vomiting—Methotrexate—testicular cancer	0.000147	0.00318	CcSEcCtD
Rocuronium—Rash—Methotrexate—testicular cancer	0.000146	0.00315	CcSEcCtD
Rocuronium—Dermatitis—Methotrexate—testicular cancer	0.000146	0.00315	CcSEcCtD
Rocuronium—Pruritus—Doxorubicin—testicular cancer	0.000142	0.00306	CcSEcCtD
Rocuronium—Vomiting—Epirubicin—testicular cancer	0.000138	0.00297	CcSEcCtD
Rocuronium—Nausea—Methotrexate—testicular cancer	0.000138	0.00297	CcSEcCtD
Rocuronium—Rash—Epirubicin—testicular cancer	0.000137	0.00295	CcSEcCtD
Rocuronium—Dermatitis—Epirubicin—testicular cancer	0.000137	0.00294	CcSEcCtD
Rocuronium—Nausea—Epirubicin—testicular cancer	0.000129	0.00278	CcSEcCtD
Rocuronium—Vomiting—Doxorubicin—testicular cancer	0.000128	0.00275	CcSEcCtD
Rocuronium—Rash—Doxorubicin—testicular cancer	0.000127	0.00273	CcSEcCtD
Rocuronium—Dermatitis—Doxorubicin—testicular cancer	0.000126	0.00272	CcSEcCtD
Rocuronium—Nausea—Doxorubicin—testicular cancer	0.000119	0.00257	CcSEcCtD
